What does ISI LAB do?

ISI LAB is a shop in Anderlecht. Private Limited, started on 8 January 2019, 1 establishment.

What is the address of ISI LAB?

The registered office of ISI LAB is located at Sylvain Dupuislaan 209, 1070 Anderlecht.

Is ISI LAB still active?

Yes. According to the CBE (31 October 2026) ISI LAB is active, legal situation “Normale toestand”, started on 8 January 2019.

Is ISI LAB registered on Peppol?

Yes, ISI LAB is registered on the Peppol network with ID 0208:0717791486.

What is the enterprise number of ISI LAB?

The enterprise number of ISI LAB is BE0717791486.

When was ISI LAB founded?

ISI LAB was founded on 8 January 2019.

Who are the directors of ISI LAB?

According to the 2025 annual accounts, the directors of ISI LAB are: Frédéric Charon.

Is ISI LAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 January 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ISI LAB make in 2025?

ISI LAB recorded a loss after taxes of € 24,702 in financial year 2025.

What is the revenue of ISI LAB?

As a small company, ISI LAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -23,206.

Does ISI LAB have a website?

Yes, ISI LAB has a website at isi-clinique.be.

ISI LAB (Private Limited) - Anderlecht - BE0717791486

Dossier ISI LAB, printed on 31 October 2026 from databakkes.be/en/0717791486/isi-lab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

ISI LAB from Anderlecht, company number BE0717791486, closed financial year 2025 with a result of € -24,702 after tax. For that financial year ISI LAB recorded a gross margin of € -23,206 and equity of € 29,518. Compared with financial year 2024, the result moved from € -24,633 to € -24,702. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Healthy

€ 29,518

▼ 46% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -24,702

Profit after tax over the fiscal year.

Cash in the bank

€ 28,622

▼ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 23,318.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,942

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 60,915 Gross margin 2022: € 60,915 First fiscal year in the series	€ -918 Gross margin 2023: € -918 ▼ € 61,833 vs 2022 (€ 60,915) Unfavourable step	€ -21,506 Gross margin 2024: € -21,506 ▼ € 20,588 vs 2023 (€ -918) Unfavourable step	€ -23,206 Gross margin 2025: € -23,206 ▼ € 1,700 vs 2024 (€ -21,506) Unfavourable step	▼ € 1,700
Profit after taxes	€ 2,935 Profit after taxes 2022: € 2,935 First fiscal year in the series	€ -40,329 Profit after taxes 2023: € -40,329 ▼ € 43,264 vs 2022 (€ 2,935) Unfavourable step	€ -24,633 Profit after taxes 2024: € -24,633 ▲ € 15,696 vs 2023 (€ -40,329) Favourable step	€ -24,702 Profit after taxes 2025: € -24,702 Unchanged (€ -24,633) Unfavourable step
Equity	€ 119,182 Equity 2022: € 119,182 First fiscal year in the series	€ 78,853 Equity 2023: € 78,853 ▼ 34% vs 2022 (€ 119,182) Unfavourable step	€ 54,220 Equity 2024: € 54,220 ▼ 31% vs 2023 (€ 78,853) Unfavourable step	€ 29,518 Equity 2025: € 29,518 ▼ 46% vs 2024 (€ 54,220) Unfavourable step	▼ 46%
Total debts	€ 55,536 Total debts 2022: € 55,536 First fiscal year in the series	€ 12,520 Total debts 2023: € 12,520 ▼ 77% vs 2022 (€ 55,536) Favourable step	€ 2,083 Total debts 2024: € 2,083 ▼ 83% vs 2023 (€ 12,520) Favourable step	€ 1,942 Total debts 2025: € 1,942 ▼ 7% vs 2024 (€ 2,083) Favourable step	▼ 7%
Cash	€ 90,130 Cash 2022: € 90,130 First fiscal year in the series	€ 84,556 Cash 2023: € 84,556 ▼ 6% vs 2022 (€ 90,130) Unfavourable step	€ 53,128 Cash 2024: € 53,128 ▼ 37% vs 2023 (€ 84,556) Unfavourable step	€ 28,622 Cash 2025: € 28,622 ▼ 46% vs 2024 (€ 53,128) Unfavourable step	▼ 46%
Retained profit	€ 112,982 Retained profit 2022: € 112,982 First fiscal year in the series	€ 72,653 Retained profit 2023: € 72,653 ▼ 36% vs 2022 (€ 112,982) Unfavourable step	€ 48,020 Retained profit 2024: € 48,020 ▼ 34% vs 2023 (€ 72,653) Unfavourable step	€ 23,318 Retained profit 2025: € 23,318 ▼ 51% vs 2024 (€ 48,020) Unfavourable step	▼ 51%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 319 Bank debt 2024: € 319 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 319) Favourable step	▼ 100%
Balance sheet total	€ 174,718 Balance sheet total 2022: € 174,718 First fiscal year in the series	€ 91,374 Balance sheet total 2023: € 91,374 ▼ 48% vs 2022 (€ 174,718) Unchanged	€ 56,303 Balance sheet total 2024: € 56,303 ▼ 38% vs 2023 (€ 91,374) Unchanged	€ 31,460 Balance sheet total 2025: € 31,460 ▼ 44% vs 2024 (€ 56,303) Unchanged	▼ 44%

Key figures of ISI LAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ISI LAB?

What happened at ISI LAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: loss of € 24,702. Source: NBB ↗
Jan 8, 2019 New establishment in Anderlecht. KBO
2019 Frédéric Charon became a director. NBB
Jan 8, 2019 Start of the company according to the CBE. KBO

In short

From € 2,935 profit in 2022 to € 24,702 loss in 2025.

Paid € 2,524 in corporate taxes since 2022.

Best year ever: 2022, with € 2,935 profit.

Original PDFs at the National Bank ↗

Management

Frédéric Charon

ISI LAB

Behind ISI LAB is Frédéric Charon.

Directors

According to the 2025 annual accounts

Frédéric Charon

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Sylvain Dupuislaan 209

1070 Anderlecht

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

DTD Services

€ 48,574 gross margin · 2025

Laboratoire Vital Santé

€ -12,231 gross margin · 2025

ISI CLINIC

€ 37,290 gross margin · 2025

ISI Services

€ -5,633 gross margin · 2025

AR MEDIA SPRL

€ 139,811 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS isi-clinique.be

Canonical: https://www.isi-clinique.be/

Technologies

All in One SEOApacheCloudflare CDNJSElementorFont AwesomeGoogle AnalyticsGoogle FontsGoogle Tag ManagerLightboxPHPSwiperWooCommerceWordPressjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

CELESTE-AS CELESTE - Internet services provider, FR

Domain

isi-clinique.be

Registered

2008-11-24

Website info

HTTPS Ja

Indexable pages 33

Languages FR

Features

Webshop Ads

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0717.791.486

VAT number

BE 0717.791.486

Registered office

Sylvain Dupuislaan 209, 1070 Anderlecht

Names & denominations

ISI LAB

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 January 2019

Peppol

Active · Active since 17 Sept 2025

Contact

isi-clinique.be +3225214444

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Groothandel in farmaceutische en medische artikelen

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

View on CBE Public ↗ Annual accounts (NBB) ↗

ISI LAB

Warning lights

Financials

What happened to ISI LAB?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions